Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Archives of Virology
Published in: Archives of Virology 3/2011

01-03-2011 | Annotated Sequence Record

Mediterranean and central-eastern European countries host viruses of two different clades of plum pox virus strain M

Authors: Sylvie Dallot, Miroslav Glasa, Darko Jevremovic, Ivanka Kamenova, Svetlana Paunovic, Gérard Labonne

Published in: Archives of Virology | Issue 3/2011

Login to get access

Abstract

The genetic diversity of plum pox virus strain M (PPV-M) was assessed by analyzing 28 isolates collected in 8 European countries. Two genomic fragments spanning the (Cter)P3-6K1-(Nter)CI coding region as well as the full coat protein coding region were sequenced directly from PCR products. Phylogenetic analysis showed that the geographical origin of the collected isolates was clearly associated with two different PPV-M clades. Moreover, the pattern of substitutions in the CP gene shed light on the evolutionary relationships between PPV-M and the recombinant strains PPV-Rec and PPV-T.
Appendix
Available only for authorised users
Literature
1.
Candresse T, Cambra M (2006) Causal agent of Sharka disease: historical perspective and current status of Plum pox virus strains. EPPO Bull 36:239–326CrossRef
2.
Dallot S, Glasa M, Kamenova I, Paunović S, Pittnerova S, Kominek P, Jevremović D, Virscek-Marn M, Mavric Plesko I, Milusheva S (2008) Prevalence and genetic structure of PPV-M in six European countries. Acta Hort 781:227–234
3.
Garcia JA, Cambra M (2007) Plum pox virus and sharka disease. Plant Viruses 1:69–79
4.
Glasa M, Candresse T (2005) Partial sequence analysis of an atypical Turkish isolate provides further information on the evolutionary history of Plum pox virus (PPV). Virus Res 108:199–206PubMedCrossRef
5.
Glasa M, Palkovics L, Komínek P, Labonne G, Pittnerová S, Kúdela O, Candresse T, Subr Z (2004) Geographically and temporally distant natural recombinant isolates of Plum pox virus (PPV) are genetically very similar and form a unique PPV subgroup J. Gen Virol 85:2671–2681CrossRef
6.
Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41:95–98
7.
Myrta A, Boscia D, Potere O, Kolber M, Nemeth M, Terlizzi B, Cambra M, Savino V (2001) Existence of two serological subclusters of Plum pox virus, strain M. Eur J Plant Pathol 107:845–848CrossRef
8.
Serçe ÇU, Candresse T, Svanella-Dumas L, Krizbai L, Gazel M, Çaglayan K (2009) Further characterization of a new recombinant group of Plum pox virus isolates, PPV-T, found in orchards in the Ankara province of Turkey. Virus Res 142:121–126PubMedCrossRef
9.
Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol and Evol 24:1596–1599CrossRef
Metadata
Title
Mediterranean and central-eastern European countries host viruses of two different clades of plum pox virus strain M
Authors
Sylvie Dallot
Miroslav Glasa
Darko Jevremovic
Ivanka Kamenova
Svetlana Paunovic
Gérard Labonne
Publication date
01-03-2011
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 3/2011
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-011-0918-y

Other articles of this Issue 3/2011

Archives of Virology 3/2011 Go to the issue

Original Article

MHV-68 Open Reading Frame 20 is a nonessential gene delaying lung viral clearance

Brief Report

Detection and genetic characterization of canine parvoviruses and coronaviruses in southern Ireland

Original Article

Superior protection provided by a single dose of MF59-adjuvanted whole inactivated H5N1 influenza vaccine in type 1 diabetic mice

Original Article

Complete nucleotide sequence of capsicum chlorosis virus isolated from Phalaenopsis orchid and the prediction of the unexplored genetic information of tospoviruses

Brief Report

The complete genome sequence of a Passion fruit woodiness virus isolate from Australia determined using deep sequencing, and its relationship to other potyviruses

Annotated Sequence Record

Complete nucleotide sequence of a new variant of grapevine rupestris stem pitting-associated virus from southern Italy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits